OpGen, Inc. (OPGN)
OTCMKTS
· Delayed Price · Currency is USD
4.600
+0.370 (8.75%)
Jun 4, 2025, 1:33 PM EDT
OpGen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 3.42 | 2.61 | 4.31 | 4.21 | 3.5 |
| Revenue Growth (YoY) | 31.11% | -39.45% | 2.17% | 20.46% | 18.75% |
| Cost of Revenue | 8.24 | 11.6 | 13.76 | 13.81 | 6.75 |
| Gross Profit | -4.82 | -8.99 | -9.45 | -9.6 | -3.25 |
| Selling, General & Admin | 10.86 | 13.23 | 13.65 | 11.9 | 7.72 |
| Operating Expenses | 10.86 | 13.23 | 13.65 | 11.9 | 7.72 |
| Operating Income | -15.69 | -22.22 | -23.1 | -21.49 | -10.97 |
| Interest Expense | -1.84 | -3.26 | -4.8 | -3.4 | -0.19 |
| Interest & Investment Income | 0.14 | 0.05 | 0.05 | 0.11 | 0.01 |
| Currency Exchange Gain (Loss) | -0.29 | 0.38 | 0.89 | -1.47 | 0 |
| Other Non Operating Income (Expenses) | 0.07 | 0.11 | -7.89 | 0.52 | 0 |
| EBT Excluding Unusual Items | -17.61 | -24.93 | -34.85 | -25.74 | -11.15 |
| Merger & Restructuring Charges | - | - | - | -0.47 | -0.78 |
| Impairment of Goodwill | - | -6.94 | - | - | - |
| Gain (Loss) on Sale of Assets | -12.98 | - | - | 0.1 | - |
| Asset Writedown | -2.08 | -5.41 | -0.17 | -0.85 | -0.52 |
| Other Unusual Items | - | - | 0.26 | 0.88 | - |
| Pretax Income | -32.67 | -37.28 | -34.76 | -26.08 | -12.45 |
| Income Tax Expense | - | - | 0.04 | 0.13 | - |
| Net Income | -32.67 | -37.28 | -34.81 | -26.21 | -12.45 |
| Preferred Dividends & Other Adjustments | - | - | 7.17 | - | - |
| Net Income to Common | -32.67 | -37.28 | -41.97 | -26.21 | -12.45 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | - |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | - |
| Shares Change (YoY) | 222.67% | 33.15% | 132.10% | - | - |
| EPS (Basic) | -41.47 | -152.70 | -228.89 | -331.77 | - |
| EPS (Diluted) | -41.47 | -152.70 | -228.89 | -331.77 | - |
| Free Cash Flow | -15.12 | -21.04 | -23.46 | -23.53 | -11.54 |
| Free Cash Flow Per Share | -19.19 | -86.18 | -127.95 | -297.79 | - |
| Gross Margin | -141.11% | - | -219.53% | -227.76% | -93.02% |
| Operating Margin | -458.95% | -852.18% | -536.51% | -510.02% | -313.59% |
| Profit Margin | -955.69% | -1429.96% | -974.74% | -621.93% | -355.75% |
| Free Cash Flow Margin | -442.32% | -806.99% | -544.88% | -558.25% | -329.77% |
| EBITDA | -14.37 | -20.58 | -20.39 | -19.16 | -10.05 |
| EBITDA Margin | - | - | - | - | -287.26% |
| D&A For EBITDA | 1.32 | 1.64 | 2.71 | 2.33 | 0.92 |
| EBIT | -15.69 | -22.22 | -23.1 | -21.49 | -10.97 |
| Revenue as Reported | 3.42 | 2.61 | 4.31 | 4.21 | 3.5 |
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.